Curtiswyss logo

WORLD ADOPTIVE T-CELL THERAPY SUMMIT

May 29 - 30, 2017

Curtis & Wyss Group is pleased to invite you to "World Adoptive T-Cell Therapy Summit" scheduled on May 29 - 30, 2017 in Lisbon, Portugal

By joining this summit of Curtis & Wyss Group, you will discuss and learn about the current issues on Adoptive T-Cell Therapy. This is an opportunity for thought leaders from biotech, big pharma, academia and the wider service community to discuss progress and share insight on strategies. This is a pivotal moment particularly because clinical progress has been made with Chimeric Antigen Receptors (CAR), T Cell Receptors (TCR), and Tumor Infiltrating Lymphocytes (TIL), making these therapies the frontrunner for curing immune-based diseases.

Therefore, we are pleased to invite you to the "World Adoptive T-Cell Therapy Summit" scheduled on May 29 - 30, 2017 in Lisbon, Portugal. This premier B2B event will enable the participants to learn about the latest developments of Adoptive T-Cell Therapy. It is an honor and privilege to invite you to participate in this Summit.

We look forward to welcoming you at the Summit in Lisbon upcoming May!

Key Practical Learning Points of the Summit:

  • Advancements in T-cell engineering
  • Efficacy in different cancer models
  • Results from human and clinical studies
  • Commercialization of Viable T-cell therapies
  • Scaling and manufacture of T-cells
  • Developing adoptive cell therapies for solid tumors
  • Clinical case studies on T cell receptors and their biology
  • Critical components needed to make adoptive T cell therapies viable
  • Advancements in T-cell engineering
  • Efficacy in different cancer models
  • Who should attend? Chief Executives, Executive Directors, Vice Presidents, Heads, Team Leaders and Managers of:

  • Clinical Research/Development
  • Clinical Operations
  • Clinical Oncology
  • Cancer Immunotherapy
  • Immunology
  • Translational Research/Development/Medicine
  • Medical Affairs
  • R&D Innovation & Strategy
  • Biomarkers
  • Business Development
  • Corporate Venture
  • Licensing
  • Strategic Partnerships
  • Negotiations
  • Commercial Innovation
  • From Industries

  • Pharmaceutical,
  • Biotechnology,
  • Research Institutes, etc
  • Details

    Start:
    May 29
    End:
    May 30

    Location

    Lisbon, Portugal
    Event Programme Request